"Le CHIC Alençon-Mamers est l'établissement support du Groupement Hospitalier de Territoire Orne-Perche-Saosnois (GHT OPS)"

During the past decade, Chi D Alencon; Medecine Ambulatoire conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chi D Alencon; Medecine Ambulatoire" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Centre Francois Baclesse" with 1 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 1 trials sponsored, "MedtronicNeuro" with 1 trials sponsored and "University Hospital, Grenoble" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chi D Alencon; Medecine Ambulatoire" #1 collaborator was "Floralis" with 1 trials as a collaborator, "Medtronic France SAS" with 1 trials as a collaborator, "National Cancer Institute, France" with 1 trials as a collaborator and "Société Française d'Anesthésie et de Réanimation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Chi D Alencon; Medecine Ambulatoire" are "Colorectal Cancer" (3 trials), "Over Active Bladder" (1 trials), "Pain Cancer" (1 trials), "Surgery" (1 trials) and "Urinary Incontinence" (1 trials). Many other conditions were trialed in "Chi D Alencon; Medecine Ambulatoire" in a lesser frequency.

Most popular intervention types in "Chi D Alencon; Medecine Ambulatoire" are "Drug" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Sacral Nerve Modulation" (1 trials), "Therapeutic education Programm" (1 trials), "ambulatory surgery description" (1 trials) and "fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chi D Alencon; Medecine Ambulatoire" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Chi D Alencon; Medecine Ambulatoire". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Chi D Alencon; Medecine Ambulatoire, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chi D Alencon; Medecine Ambulatoire, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".